Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 2/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.54 |
| ▸ | ICMT | O60725 | 15/20 | 0.52 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | FNTA | P49354 | 1/20 | 0.39 |
| ▸ | FNTB | P49356 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1819486 | 0.77 | ALDH1A1 (0.55) | MAPTALDH1A1ICMT | |
| SCHEMBL1819480 | 0.77 | ALDH1A1 (0.55) | MAPTALDH1A1ICMT | |
| SCHEMBL20218608 | 0.77 | ALDH1A1 (0.55) | MAPTALDH1A1ICMT | |
| SCHEMBL1819482 | 0.77 | ALDH1A1 (0.55) | MAPTALDH1A1ICMT | |
| SCHEMBL20218672 | 0.75 | MAPT (0.77) | MAPTALDH1A1ICMTMEN1TRPA1 | |
| SCHEMBL3422499 | 0.75 | MAPT (0.77) | MAPTALDH1A1ICMTMEN1TRPA1 | |
| SCHEMBL3422497 | 0.75 | MAPT (0.77) | MAPTALDH1A1ICMTMEN1TRPA1 | |
| SCHEMBL3422493 | 0.75 | MAPT (0.77) | MAPTALDH1A1ICMTMEN1TRPA1 | |
| SCHEMBL3420366 | 0.74 | MAPT (0.72) | MAPTALDH1A1ICMTMEN1TRPA1 | |
| SCHEMBL3420372 | 0.74 | MAPT (0.72) | MAPTALDH1A1ICMTMEN1TRPA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10314802-B2 | Isoprenyl compounds and methods thereof | SIGNUM BIOSCIENCES, INC. (US) | 2019-06-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10314802-B2 | Isoprenyl compounds and methods thereof | ALOX15B, ALOX15, ALOX5 | MAPT 4014/4885ALDH1A1 882/4885ICMT 267/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.